دورية أكاديمية

Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer

التفاصيل البيبلوغرافية
العنوان: Primary results of the AGO-Zervix-1 Study: A prospective, randomized phase III study to compare the effects of paclitaxel and topotecan with those of cisplatin and topotecan in the treatment of patients with recurrent and persistent cervical cancer
المؤلفون: Gass, Paul, Thiel, Falk C., Häberle, Lothar, Ackermann, Sven, Theuser, Anna-Katharin, Hummel, Nadine, Boehm, Sibylle, Kimmig, Rainer, Reinthaller, Alexander, Becker, Sven, Hilpert, Felix, Janni, Wolfgang, Vergote, Ignace, Harter, Phlipp, Emons, Julius, Hein, Alexander, Beckmann, Matthias W., Fasching, Peter A., Pöschke, Patrik
المصدر: In Gynecologic Oncology April 2024 183:25-32
قاعدة البيانات: ScienceDirect
الوصف
تدمد:00908258
DOI:10.1016/j.ygyno.2024.03.002